BioCentury
ARTICLE | Company News

Draxis, Block Drug Co. Inc. deal

May 8, 2000 7:00 AM UTC

BLOCA's Block Drug Co. (Canada) Ltd. subsidiary will purchase DRAX's Spectro line of over-the-counter dermatology products for C$12.5 million (US$8.5 million). DRAX said annual revenues for the produc...